December 4, 2025, 8 AM PT, 11 AM ET
The biopharma world is evolving rapidly, driven by rising demand for biologics and advanced therapeutics. To stay ahead, companies are adopting smart technologies and empowering teams to embrace new production methods while meeting strict regulatory standards. As outsourcing to CDMOs increases and processes grow more complex, agility and skilled teams are essential for long-term success.
This webinar explores how NorthX Biologics leverages modern tools—like gloveless isolators for aseptic vial filling—to enhance precision and reduce waste. Their use of flexible, GMP-compatible technology accelerated the transition from lab to clinic, enabling small, custom batches for personalized medicine. NorthX’s approach combines technology with continuous learning, ensuring teams remain sharp and adaptable. They will share their qualification and validation strategy, contamination control practices, and insights from engaging with regulators about gloveless isolators.
In this webinar you’ll:
- Discover how gloveless isolator technology enhances aseptic filling precision and reduces waste
- Learn NorthX Biologics’ approach to qualification, validation, and contamination control
- Gain insights into strategies for engaging with regulators on implementing advanced aseptic systems
Who should attend:
- Biopharma manufacturing leaders – interested in modernizing aseptic filling operations and improving production agility
- CDMO executives and operations managers – seeking scalable, GMP-compliant technologies to support client needs
- Quality and regulatory affairs professionals – looking to understand best practices in quality risk management, validation, and regulatory engagement for advanced aseptic systems
Offered Free by: Cytiva and American Pharmaceutical Review
See All Resources from: Cytiva and American Pharmaceutical Review
